Taming the "other" claims cost monster - with Surya Singh

This week’s episode features a conversation with Surya Singh, CEO and Co-founder at gWell. Muskoskeletal claims are growing monster that gobbles up claims spends. Cutting-edge tech in genomics, AI, and machine learning help create diagnostics for the best treatments since many chronic conditions have genetic markers associated with them. At the same time, this technology cuts costs by as much as a third of current spends, a significant percentage that’s of interest to employers and patients alike.

SPONSOR: ShiftShapers Strategies (www.shiftshapersstrategies.com)